Oragenics, Inc. (OGEN)
0.6058
+0.01
(+0.95%)
USD |
NYAM |
May 29, 16:00
0.607
0.00 (0.00%)
After-Hours: 20:00
Oragenics Shareholders Equity (Quarterly) : 6.182M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Anika Therapeutics, Inc. | 133.90M |
| Savara, Inc. | 176.04M |
| Vericel Corp. | 356.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.490M |
| Total Liabilities (Quarterly) | 1.308M |
| Debt to Equity Ratio | 0.0091 |
| Current Ratio | 5.726 |
| Net Debt Paydown Yield | 11.82% |